ASPIRE GCT: A single-arm, phase II clinical trial of aspirin to prevent venous thromboembolism in patients with advanced germ cell tumors receiving chemotherapy
Recommended Citation
Brown LC, McCormack MJ, Ruggeri A, et al. ASPIRE GCT: A single-arm, phase II clinical trial of aspirin to prevent venous thromboembolism in patients with advanced germ cell tumors receiving chemotherapy. Journal of Clinical Oncology. 2026/03/01 2026;44(7_suppl):TPS624-TPS624. doi:10.1200/JCO.2026.44.7_suppl.TPS624
Document Type
Abstract
Affiliations
Atrium Health Wake Forest Baptist Comprehensive Cancer Center